{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:07:20Z","timestamp":1792282040538,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.radonc.2015.08.018","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T08:58:07Z","timestamp":1441443487000},"page":"262-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints"],"prefix":"10.1016","volume":"117","author":[{"given":"Max","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem","family":"van der Voort van Zyp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"van de Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metha","family":"Maenhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Kattevilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Vulpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.08.018_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-410X.2009.08715.x","article-title":"Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy","volume":"105","author":"Kimura","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.radonc.2015.08.018_b0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.08.018_b0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2012.04.028","article-title":"Feasibility of MR imaging\/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer","volume":"85","author":"Hsu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2014.06.013","article-title":"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life","volume":"112","author":"Peters","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.018_b0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/iju.12373","article-title":"Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy","volume":"21","author":"Sasaki","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.radonc.2015.08.018_b0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brachy.2005.01.002","article-title":"Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk","volume":"4","author":"Crook","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","article-title":"Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy","volume":"83","author":"Salembier","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.018_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American brachytherapy society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2010.01.022","article-title":"Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate","volume":"80","author":"Roeloffzen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2012.06.001","article-title":"Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: a matched case-control study","volume":"104","author":"Earley","year":"2012","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2015.08.018_b0060","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(05)00681-6","article-title":"Risk factors for the development of prostate brachytherapy related urethral strictures","volume":"175","author":"Merrick","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2015.08.018_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brachy.2007.03.003","article-title":"The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry","volume":"6","author":"Neill","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brachy.2009.06.007","article-title":"Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy","volume":"9","author":"Moman","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2013.07.009","article-title":"Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review","author":"Alongi","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2015.08.018_b0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semradonc.2013.01.006","article-title":"Cancer control and complications of salvage local therapy after failure of radiotherapy for prostate cancer: a systematic review","volume":"23","author":"Parekh","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2015.08.018_b0090","article-title":"Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial","volume":"12","author":"Lips","year":"2011"},{"key":"10.1016\/j.radonc.2015.08.018_b0095","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 gy versus 80 gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2009.11.003","article-title":"I-125 seed planning: an alternative method of urethra definition","volume":"94","author":"Anderson","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.018_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1538-4721(03)00005-9","article-title":"Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy","volume":"2","author":"Stone","year":"2003","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brachy.2009.09.007","article-title":"Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy","volume":"9","author":"Ishiyama","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0360-3016(03)00583-2","article-title":"Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2007.10.030","article-title":"An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors","volume":"88","author":"Steggerda","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.018_b0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0360-3016(01)02658-X","article-title":"Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation","volume":"52","author":"Crook","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ijrobp.2004.01.041","article-title":"Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity","volume":"59","author":"Eapen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2004.01.045","article-title":"Acute urinary retention after transperineal template-guided prostate biopsy","volume":"59","author":"Buskirk","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brachy.2006.08.003","article-title":"A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy","volume":"5","author":"Heysek","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2015.08.018_b0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijrobp.2008.04.009","article-title":"Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer","volume":"73","author":"Saibishkumar","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.018_b0150","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2008.09.013","article-title":"Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants","volume":"91","author":"Moerland","year":"2009","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:54:03Z","timestamp":1537365243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015004430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0167814015004430"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.018","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}